Health Condition 1: E230- Hypopituitarism
Conditions
Interventions
Intervention1: IV Zolendronate: IV Zolendronate infusion 5mg single dose along with standard care of treatment.
Participants will continue to receive standard treatment in the form of hormone replacem
Sponsors
Battu Sree Vaishnavi
Eligibility
Inclusion criteria
Inclusion criteria: 1.Age more than or equal to 18 years 2.Patients with hypopituitarism 3.Presence of GH deficiency 4.Patient non complaint to GH treatment or in whom GH treatment is contraindicated 5. Those who have given consent
Exclusion criteria
Exclusion criteria: 1. Postmenopausal women 2. Pregnant women 3.Patients with known systemic disorders like chronic liver disease chronic kidney disease or bedridden status 4.Patients who underwent recent dental procedures in the past 3 months or planning for dental procedures in the next 3 months 5.Patients who do not give consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Primary outcome - Bone mineral density at baseline and at the end of 1 yearTimepoint: Primary outcome - Bone mineral density at baseline and at the end of 1 year | — |
Secondary
| Measure | Time frame |
|---|---|
| Z Score at baseline & at the end of 1 yearTimepoint: Z Score at baseline & at the end of 1 year | — |
Countries
India
Contacts
Public ContactBattu Sree Vaishnavi
All India Institute of Medical Sciences, Raipur
Outcome results
None listed